THE German government will limit their use of the vaccine BioNTech/Pfizer against Covid-19, giving precedence to its respective formulation Modern, because the latter ‘s stocks are approaching their expiration date.
According to a letter from the federal Undersecretary of State for Health Thomas Stephen to the L ,nder, relied on by RND network, in the near future and in view of the commemorative vaccinations, the federation will deliver less vaccines to the vaccination centers and to the family doctors BioNTech/Pfizer, in order to use its vaccines Modern at risk of being thrown out because their due date is approaching, in the middle of the first quarter of 2022. So far, their vaccines BioNTech/Pfizer represent the 90% of orders in Germany.
From next week, private clinics will be able to receive up to 30 doses of vaccine BioNTech/Pfizer per week, while the vaccination centers 1020 doses. Conversely, there will be no restriction on orders from Modern.
The development provoked reactions, with their representative Greens for issues Health Maria Klein-Smink to state in RND that “Mr. Span he had promised everyone a booster dose and now it turns out that he knowingly caused false expectations and the result will be that those who want their booster vaccination will not be able to be vaccinated quickly “.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
